Skip to main content
SpringerLink
Log in

Adenocarcinoma of the Duodenum: Importance of Accurate Lymph Node Staging and Similarity in Outcome to Gastric Cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: This study examined prognostic discrimination by lymph node staging for duodenal adenocarcinoma and compared the nodal stage–specific survival with that associated with gastric antral adenocarcinoma.

Method: Prospectively maintained databases from 1983 to 2000 were reviewed to identify 137 patients with duodenal adenocarcinoma and 545 patients with gastric antral adenocarcinoma at a single institution.

Results: R0 resection was performed for 72 patients with duodenal cancer. At least 15 lymph nodes were retrieved in 34 cases (47%). Lymph node metastasis (pN+) was detected in 31 patients (43%). With median follow-up of 36 months, the pN category was an independently significant prognostic factor (pN0, 5-year disease-specific survival of 83%, vs. pN+, 56%; P = .03). The survival difference between pN0 and pN+ was pronounced in patients with ≥15 nodes (100% vs. 47%, respectively; P = .01) but was lost in those with <15 nodes (75% vs. 64%; P = .5). For gastric antrum cancer, 331 patients had R0 resection, and ≥15 nodes were retrieved in 256 cases (77%). Lymph node metastasis was detected in 157 cases (47%). For patients with ≥15 nodes, 5-year survival with pN0 (87%) or pN+ (44%) was not significantly different from the corresponding categories for duodenal adenocarcinoma.

Conclusion: For duodenal adenocarcinoma, examination of ≥15 regional lymph nodes improved prognostic discrimination by the pN category. With accurate nodal staging, pN0 was associated with excellent prognosis. With pN+, prognosis was similar to that for gastric antral adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998; 227: 821–31.

    Article  PubMed  CAS  Google Scholar 

  2. Weiss NS, Yang C. Incidence of histologic types of cancer of the small intestine. J Natl Cancer Inst 1987; 78: 653.

    PubMed  CAS  Google Scholar 

  3. Joesting DR, Beart RW, van Heerden JA, Weiland LH. Improving survival in adenocarcinoma of the duodenum. Am J Surg 1981; 141: 228–31.

    Article  PubMed  CAS  Google Scholar 

  4. Rose DM, Hochwald SN, Klimstra DS, Brennan MF. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 1996; 183: 89–96.

    PubMed  CAS  Google Scholar 

  5. Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF. Factors predictive of survival in ampullary carcinoma. Ann Surg 1998; 228: 87–94.

    Article  PubMed  CAS  Google Scholar 

  6. Fong Y, Blumgart LH, Lin E, Fortner JG, Brennan MF. Outcome of treatment for distal bile duct cancer. Br J Surg 1996; 83: 1712–5.

    Article  PubMed  CAS  Google Scholar 

  7. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathological analysis of 5-year survivors. Ann Surgery 1996; 223: 273–9.

    Article  CAS  Google Scholar 

  8. Brennan MF. Duodenal cancer. Asian J Surgery 1990; 13: 204–9.

    Google Scholar 

  9. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. Ann Surg 1998; 228: 449–61.

    Article  PubMed  CAS  Google Scholar 

  10. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than number? An analysis of 1038 patients. Ann Surg 2000; 232: 362–71.

    Article  PubMed  CAS  Google Scholar 

  11. Flemming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.

    Google Scholar 

  12. Sexe RB, Wade TP, Virgo KS, Johnson FE. Incidence and treatment of periampullary duodenal cancer in the U. S. veteran patient population. Cancer 1996; 77: 251–4.

    Article  PubMed  CAS  Google Scholar 

  13. Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma. Arch Surg 2000; 135: 635–42.

    Article  PubMed  CAS  Google Scholar 

  14. Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 1998; 2: 79–87.

    Article  PubMed  CAS  Google Scholar 

  15. Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA. Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg 2000; 135: 1070–5.

    Article  PubMed  CAS  Google Scholar 

  16. Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg 2000; 179: 37–41.

    Article  PubMed  CAS  Google Scholar 

  17. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604–8.

    Article  PubMed  CAS  Google Scholar 

  18. Bunt AM, Hogendoorn PC, van de Velde CJ, Bruijn JA, Hermans J. Lymph node staging standards in gastric cancer. J Clin Oncol 1995; 13: 2309–16.

    PubMed  CAS  Google Scholar 

  19. Bunt AM, Hermans J, van de Velde CJ, et al. Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. J Clin Oncol 1996; 14: 2289–94.

    PubMed  CAS  Google Scholar 

  20. Ohigashi H, Ishikawa O, Tamura S, et al. Pancreatic invasion as the prognostic indicator of duodenal adenocarcinoma treated by pancreaticoduodenectomy plus extended lymphadenectomy. Surgery 1998; 124: 510–5.

    PubMed  CAS  Google Scholar 

  21. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725–30.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

    Abeezar I. Sarela MD, Murray F. Brennan MD, Martin S. Karpeh MD & Kevin C. P. Conlon MD

  2. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York

    David Klimstra MD

  3. Department of Surgery, Memorial Hospital, 1275 York Ave., New York, NY, 10021

    Murray F. Brennan MD

Authors
  1. Abeezar I. Sarela MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Murray F. Brennan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin S. Karpeh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Klimstra MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kevin C. P. Conlon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Murray F. Brennan MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarela, A.I., Brennan, M.F., Karpeh, M.S. et al. Adenocarcinoma of the Duodenum: Importance of Accurate Lymph Node Staging and Similarity in Outcome to Gastric Cancer. Ann Surg Oncol 11, 380–386 (2004). https://doi.org/10.1245/ASO.2004.05.021

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2004.05.021

Key Words:

Search

Navigation